BSYI — BioSyntech Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2005 March 31st | 2006 March 31st | 2007 March 31st | R2008 March 31st | 2009 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.178 | 0.062 | 0.244 | 0.274 | 0.041 |
Cost of Revenue | |||||
Gross Profit | 0.098 | 0.041 | 0.154 | 0.172 | 0.025 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.32 | 6.92 | 8.36 | 9.54 | 13 |
Operating Profit | -5.14 | -6.85 | -8.11 | -9.27 | -12.9 |
Net Income Before Taxes | -5.14 | -6.85 | -8.11 | -9.27 | -12.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.14 | -6.85 | -8.11 | -9.27 | -12.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.14 | -6.85 | -8.11 | -9.27 | -12.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -5.14 | -6.85 | -8.11 | -9.27 | -12.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.142 | -0.167 | -0.086 | -0.097 | -0.116 |
Dividends per Share |